Yahoo Web Search

  1. The FDA granted approval to Lilly’s LLY psoriasis injection for active ankylosing spondylitis (AS) while the European Commission approved Bristol-Myers’ BMY multiple myeloma drug, Empliciti ...

  2. 5 Cancer-Fighting Stocks to Add to Your Portfolio

    Zacks via Yahoo FinanceSep 03 11:02 AM

    Doctors and researchers across the world have so far found more than 100 diseases, which can be collectively called cancer. Companies that focus on prevention of cancer produce cessation ...

  3. Notably, Semma is using a differentiated therapeutic approach to treat type I diabetes by developing stem cell-derived human islets that have the potential to restore insulin secretion and ...

  4. J&J's Stelara Gets Approval in EU for Ulcerative Colitis

    Zacks via Yahoo FinanceSep 05 14:18 PM

    Johnson & Johnson JNJ announced that the European Commission (EC) has approved the label expansion of Stelara (ustekinumab) for the treatment of adults with moderately-to-severely active ulcerative ...

  5. Today's Research Daily features new research reports on 16 major stocks, including Caterpillar (CAT), General Motors (GM) and Citigroup (C). These research reports have been hand-picked ...

  6. Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?

    Motley Fool via Yahoo FinanceSep 05 15:12 PM

    In March, the Food and Drug Administration issued a complete response letter -- the agency's euphemism for a rejection letter -- to Sanofi (NASDAQ: SNY) and Lexicon Pharmaceuticals ...

  7. Novartis AG NVS announced 5-year open-label treatment period (OLTP) data on migraine drug Aimovig. Patients initially received 70mg of Aimovig monthly in the OLTP. Of the 250 patients who switched ...

  8. Failure of Alzheimer’s Disease Study Creates a New Penny Stock

    Bloomberg via Yahoo FinanceSep 09 18:42 PM

    One of the two analysts tracked by Bloomberg who covers Neurotrope, Maxim’s Jason McCarthy, cut his rating to hold from buy, and removed his $16 price target on the company. Biogen ...

  9. Shares of Mylan closed up 3.9% at $19.90 on Thursday. A tentative approval generally signals that the FDA has signed off on the company's marketing application, but that it cannot sell ...

  10. International Association for the Study of Lung Cancer (IASLC) 2019 World Conference - Sept. in Barcelona, Spain 32nd European College of Neuropsychopharmacology (ECNP) Congress – Sept. in Copenhagen ...

  1. Ads
    related to ELI LILLY AND COMPANY